Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Moderna, Inc. - Common Stock (NQ: MRNA )

31.09 -2.49 (-7.42%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Moderna Stock Hasn't Been This Cheap Since 2020: Is Now the Time to Buy?
Pfizer recently slashed its guidance and that could be a big warning for Moderna investors as well. 
Via The Motley Fool
Moderna Announces First Participant Dosed in Phase 3 Study of mRNA-1083, a Combination Vaccine Against Influenza and COVID-19
Via ACCESSWIRE
The Best Stocks to Invest $5,000 In Right Now
Today, the following three healthcare players look like fantastic bargains. 
Via The Motley Fool
Amid A Crypto Rally, Cathie Wood's Ark Invest Sells Coinbase, Grayscale Bitcoin Trust, Buys Robinhood Shares
On Monday, Cathie Wood-led Ark Invest made a notable move by selling shares of Coinbase Global Inc (NASDAQ:COIN) amid a surge in Bitcoin (CRYPTO: BTC) prices. 
Via Benzinga
Moderna Unusual Options Activity
Via Benzinga
3 Healthcare Stocks to Invest in for a Big Shot of Gains
While healthcare stocks are down for the most part this year, there are a few names that offer the promise of big future profits. 
Via InvestorPlace
Moderna to Host Second Digital Investor Event on November 8th, 2023
Via ACCESSWIRE
Check Out What Whales Are Doing With MRNA
Via Benzinga
Moderna Unusual Options Activity For October 12
Via Benzinga
3 No-Brainer Stocks to Buy Right Now for Less than $100
You can start with a small investment and win big over time. 
Via The Motley Fool
Is It Time to Buy the S&P 500's 3 Worst-Performing Stocks This Year?
Venture beyond the headlines on a journey among 2023's least celebrated S&P 500 stocks. A roadmap to informed investment decisions awaits. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Why Moderna Stock Is Sinking This Week
Investors appear to believe that bad news for Pfizer could mean bad news for Moderna. 
Via The Motley Fool
3 Stocks That Are Dead in the Water
These three stocks to avoid once had promising futures, but their best moments are now behind them. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Top Biotech Stocks to Buy Right Now
Both companies are known innovators. 
Via The Motley Fool
Pfizer Reportedly Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid
The transition to the commercial market is planned for 2024 and could bolster sales. 
Via Investor's Business Daily
Pfizer and Moderna Don't See Eye to Eye on This 1 Particular Point
The coronavirus vaccine leaders recently made different decisions. 
Via The Motley Fool
Exposures COVID-19
China's Quarterly GDP Grew More Than Expected
China's gross domestic product GDP grew by 4.9% in the last quarter, exceeding expectations of 4.4% growth. However, the figure was weaker than the 6.3% growth seen in the previous quarter. 
Via Talk Markets
Nvidia, United Airlines, Moderna, Lucid, Bank Of America: Why These Five Stocks Are On Investors' Horizons Today
U.S. stocks exhibited a mixed performance as the trading day drew to a close, with the Nasdaq Composite taking a dip of around 30 points. 
Via Benzinga
Topics Stocks
Exposures US Equities
What's Going On With Moderna Stock?
Moderna Inc (NASDAQ: MRNA) shares are continuing to trade lower Tuesday following Pfizer Inc's (NYSE: PFE) warning about 
Via Benzinga
Do These 5 Words From Pfizer Mean Trouble for Novavax?
Coronavirus vaccine sales could represent recurrent annual revenue for Novavax and rivals. 
Via The Motley Fool
Exposures COVID-19
Healthcare Portfolio Focus Stocks
The macro news has been a steady headwind with rising rates offering 5% risk-free treasury yields. 
Via Talk Markets
Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion
Pfizer cut about $9 billion from its sales expectations for Covid products this year. 
Via Investor's Business Daily
Exposures COVID-19
Novavax Faces Setback, European Authority Delays Decision On Variant-Tailored COVID-19 Vaccine
Novavax Inc (NASDAQ: NVAX) faces a setback as the European Medicines Agency (EMA) delays a decision on its variant-tailored COVID-19 vaccine.  
Via Benzinga
Exposures COVID-19
The 10 Most Shorted Stocks Include 3 Tesla Rivals, But Not TSLA
Some big 2023 winners are shorted heavily, including two AI plays. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
BioNTech, Moderna And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Is Novavax Stock a Buy Now?
Is this company just a pandemic stock? 
Via The Motley Fool
Don’t Hold On: 7 Stocks to Sell Before 2024
Consider it best to jettison these seven stocks to sell from your portfolio, between now and the end of 2023. 
Via InvestorPlace
1 Artificial Intelligence Stock to Buy Hand Over Fist in October and 1 to Avoid
One of these players could win in AI -- and in the healthcare market, in general. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna to Report Third Quarter 2023 Financial Results on Thursday, November 2, 2023
Via ACCESSWIRE
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.